TD Asset Management Inc Reduces Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Key Points

• TD Asset Management Inc has reduced its stake in Intuitive Surgical by 8.4%, selling 38,821 shares, and now owns a total of 422,818 shares valued at approximately $209.4 million.
• Intuitive Surgical's stock opened at $495.86 and has a market capitalization of $177.76 billion, with a PE ratio of 69.16 and annual revenue growth of 21.4%.
• Analysts maintain a positive outlook for Intuitive Surgical, with a consensus rating of "Moderate Buy" and an average target price of $592.05.

TD Asset Management Inc trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 8.4% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 422,818 shares of the medical equipment provider's stock after selling 38,821 shares during the quarter. TD Asset Management Inc owned 0.12% of Intuitive Surgical worth $209,409,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of the company. Castleark Management LLC increased its holdings in Intuitive Surgical by 3.4% in the 4th quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock worth $47,221,000 after acquiring an additional 2,990 shares in the last quarter. Arlington Trust Co LLC boosted its stake in shares of Intuitive Surgical by 34.5% in the first quarter. Arlington Trust Co LLC now owns 745 shares of the medical equipment provider's stock worth $369,000 after acquiring an additional 191 shares during the period. Aaron Wealth Advisors LLC raised its stake in Intuitive Surgical by 3.2% during the 1st quarter. Aaron Wealth Advisors LLC now owns 2,509 shares of the medical equipment provider's stock valued at $1,243,000 after purchasing an additional 78 shares during the period. Longbow Finance SA raised its position in shares of Intuitive Surgical by 132.0% during the first quarter. Longbow Finance SA now owns 19,699 shares of the medical equipment provider's stock valued at $9,756,000 after buying an additional 11,209 shares during the last quarter. Finally, Ewing Morris & Co. Investment Partners Ltd. bought a new position in shares of Intuitive Surgical during the fourth quarter worth $454,000. Institutional investors own 83.64% of the company's stock.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, Director Jami K. Nachtsheim sold 2,400 shares of the stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the sale, the director owned 6,371 shares of the company's stock, valued at $3,312,920. This trade represents a 27.36% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Gary S. Guthart sold 7,893 shares of the firm's stock in a transaction on Monday, July 28th. The shares were sold at an average price of $498.64, for a total value of $3,935,765.52. Following the completion of the sale, the insider owned 13,187 shares in the company, valued at approximately $6,575,565.68. This represents a 37.44% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 18,303 shares of company stock worth $9,180,778 in the last 90 days. Insiders own 0.70% of the company's stock.

Wall Street Analyst Weigh In

Several analysts have commented on ISRG shares. Royal Bank Of Canada boosted their price target on shares of Intuitive Surgical from $605.00 to $615.00 and gave the stock an "outperform" rating in a research note on Wednesday, July 23rd. Evercore ISI boosted their price target on shares of Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a research report on Tuesday, July 8th. Piper Sandler reiterated an "overweight" rating and set a $595.00 price objective (up previously from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Wells Fargo & Company lifted their price objective on shares of Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a research note on Wednesday, July 23rd. Finally, Truist Financial upped their target price on shares of Intuitive Surgical from $590.00 to $600.00 and gave the company a "buy" rating in a research report on Wednesday, July 23rd. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $592.05.

Intuitive Surgical Price Performance

ISRG stock traded up $2.75 during midday trading on Tuesday, hitting $496.70. 1,335,237 shares of the stock traded hands, compared to its average volume of 1,991,944. The firm has a market cap of $178.06 billion, a P/E ratio of 69.28, a PEG ratio of 5.20 and a beta of 1.64. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The stock's fifty day simple moving average is $528.51 and its 200-day simple moving average is $534.63.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping the consensus estimate of $1.93 by $0.26. The business had revenue of $2.44 billion for the quarter, compared to analysts' expectations of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The business's revenue for the quarter was up 21.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.78 EPS. On average, research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.